Indication

Niemann-Pick disease type C

Niemann-Pick disease type C is a rare, life-limiting autosomal recessive neurovisceral lysosomal lipid storage disorder caused by pathogenic variants in either the *NPC1* or *NPC2* gene. Read more about Niemann-Pick disease type C

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Niemann-Pick disease type C therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Niemann-Pick disease type C preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Niemann-Pick disease type C.

Niemann-Pick disease type C is a rare, life-limiting autosomal recessive neurovisceral lysosomal lipid storage disorder caused by pathogenic variants in either the *NPC1* or *NPC2* gene.

These genetic defects impair endolysosomal trafficking, resulting in the abnormal intracellular accumulation of unesterified cholesterol and glycosphingolipids across multiple organ systems, predominantly damaging the brain, liver, and spleen.

It can present at any age—from neonates to older adults—with clinical hallmarks that include progressive neurodegeneration, cerebellar ataxia, vertical supranuclear gaze palsy, dysarthria, dysphagia, cognitive impairment, and variable hepatosplenomegaly.

Personalize your experience

Follow Niemann-Pick disease type C and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it